Ownership history in BB BIOTECH AG · 59 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Incyte Corporation COM (INCY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | REDUCED | 3,620,000 | -188,322 | -4.9% | 7.83% | $311.4M | $86.01 |
| 2018 Q4 | UNCHANGED | 3,808,322 | — | 0% | 7.76% | $242.2M | $63.59 |
| 2018 Q3 | ADDED | 3,808,322 | +50,000 | +1.3% | 6.96% | $263.1M | $69.08 |
| 2018 Q2 | ADDED | 3,758,322 | +60,000 | +1.6% | 7.27% | $251.8M | $67.00 |
| 2018 Q1 | UNCHANGED | 3,698,322 | — | 0% | 8.52% | $308.2M | $83.33 |
| 2017 Q4 | ADDED | 3,698,322 | +30,000 | +0.8% | 9.86% | $350.3M | $94.71 |
| 2017 Q3 | ADDED | 3,668,322 | +153,500 | +4.4% | 11.85% | $428.2M | $116.74 |
| 2017 Q2 | ADDED | 3,514,822 | +25,000 | +0.7% | 13.53% | $442.6M | $125.91 |
| 2017 Q1 | REDUCED | 3,489,822 | -390,000 | -10.1% | 15.26% | $466.5M | $133.67 |
| 2016 Q4 | UNCHANGED | 3,879,822 | — | 0% | 14.41% | $389.0M | $100.27 |
As of 2025 Q4 — sorted by position size